Today, a team of oncologists from the Cancer Research Center in Cambridge, together with their colleagues from the Oulstone Medical Center, presented a report on their new tested technology of the so-called “respiratory biopsy”. Representing a fairly new and experimental method for determining cancer cells by studying respiratory samples of potential patients, this technology has already established itself as one of the most interesting and effective – of course, tests and experiments are still ongoing, mainly in the format of testing a compact device that captures these samples.
The new technology for the diagnosis of cancer cells is based on the hypothesis that while cancer disrupts the natural course of cell creation and development, the so-called volatile organic compounds change their structure and are surrounded by new patterns and biological markers, which in turn can indicate the presence of cancer-infected cells. By capturing breath patterns, the technology allows you to look for these same patterns and biomarkers in them, thereby effectively establishing the type and characteristics of cancer.
Previously, a similar technique was used mainly for the diagnosis of lung or stomach cancer, but now advanced technology allows you to establish and register other forms and types of cancer. It is known that at the moment, developers are conducting tests involving more than 1,500 patients suffering from various forms of cancer – firstly, in order to teach their system to determine these patterns in a more correct way, and secondly, to further improve the capabilities and methods for such a diagnosis.
It is worth noting that testing of respiratory samples by means of a new respiratory biopsy was considered as a relatively effective oncological approach to diagnosis for the past ten years – however, only now, with the development of appropriate techniques and the advent of new diagnostic equipment, this idea can be translated into reality.